Purpose: Cryptogenic epilepsy, defines a group of epilepsy syndromes for which an aetiology is unknown but an underlying brain disease is suspected. We selected patients in this subgroup of epilepsy and investigated the sero-positivity rate for anti-Toxoplasma IgG antibodies by Enzyme Linked Immunosorbent Assay (ELISA). We investigated the probable relationship between Toxoplasma gondii and cryptogenic epilepsy. Methods: We selected 50 patients with cryptogenic epilepsy, 50 patients with known cause epilepsy and 50 healthy volunteers and investigated the sero-positivity rate for anti-Toxoplasma IgG antibodies by ELISA. Results: The sero-positivity rate for anti-Toxoplasma IgG antibodies among cryptogenic epilepsy patients (52%) was found to be higher than healthy volunteers (18%) and known cause epilepsy patients (22%) with statistical significance, (X 2 = 18.095, P < 0.01). Conclusion: There might be a causal relationship between chronic toxoplasmosis and the aetiology of cryptogenic epilepsy.
INTRODUCTION
Toxoplasma gondii is worldwide in distribution, is closely related to other coccidia, and also has certain similarities to malarial parasites. The parasites were first discovered in the North African rodent called the Ctenodactylus gundii, hence the species name gondii. Although serologic evidence indicates a high rate of human exposure to the organism, the disease itself is relatively rare. T. gondii can infect many vertebrates as well as humans, but the definitive host is the house cat and other members of the Felidae family 1 .
This organism is an obligate intracellular parasite and is found in two forms in humans. The actively proliferating trophozoites or tachyzoites are usually seen in the early, more acute phases of the infection. The resting forms or tissue cysts are primarily found in muscle and brain, probably as a result of the host immune response 1 .
Toxoplasma infections can be acquired postnatally and categorised into four groups:
(a) Lymphadenitis, fever, headache, and myalgia, with a possibility of splenomegaly and a brief erythematous rash (b) Typhus-like exanthemaous form with myocarditis, meningoencephalitis, atypical pneumonia, and possible death (c) Retinochoroiditis, which may be severe, requiring enucleation (d) CNS involvement, which is usually fatal 2 .
The large numbers of people who are serologically positive for T. gondii suggest that the majority of infections are benign, with most people exhibiting few (e.g. coryzal or mild "flu" like illness) or no symptoms. Overall, approximately 2.5% of AIDS patients have been diagnosed with cerebral toxoplasmosis.
The cryptogenic epilepsies are epilepsy syndromes for which an aetiology is unknown, but an underlying brain disease is suspected. They affect approximately 20% of all patients with epilepsy 3 . A diagnosis of cryptogenic epilepsy cannot be made in the presence of a family history of epilepsy, a history of head trauma, meningitis, brain surgery, an abnormal magnetic resonance imaging (MRI) study, an abnormal electroencephalogram (EEG)-such as that seen with absence of seizures-or other inherited forms of epilepsy and alcoholism. In the MRI era, many cases of cryptogenic epilepsy have been attributed to medial temporal sclerosis or congenital, neuronal migrational abnormalities previously undetectable by neuroimaging techniques 4 .
Several parasitic infections cause convulsions, most of which are easily detected by cerebrospinal fluid (CSF) analysis, serum testing, and MRI 4 . T. gondii can form dormant cysts in the brain, which are microscopic and undetectable with MRI or routine CSF analysis. T. gondii in its dormant, bradycyst form, is generally not associated with symptoms; however, with immunosupression of the host, reactivation of the bradizoites causes the potentially lethal disease, toxoplasmosis 5 . About 20% of the US population is sero-positive for immunoglobulin G (IgG) for T. gondii, making this one of the most prevalent and probably the only chronic parasitic infection lasting a human lifetime without any known consequences 6 . In France, the rate of sero-positivity has been reported to reach 80%, which may be in part explained by cultural preference for undercooked or raw meat 7 . In Turkey, the rate of sero-positivity was reported as 23.1% inİzmir 8 , and 36% in Kayseri 9 . A positive antibody titre reflects the persistence of parasites in the CNS 10 . Tissue cysts containing bradizoites may spontaneously rupture releasing parasites that cause antibody titres to remain elevated 11 . The bradycyst form of T. gondii is a prevalent, dormant parasitic infection in the brain and could have the potential to cause epilepsy, as do other parasitic infections 4 .
We selected patients from the cryptogenic epilepsy subpopulation and tested them with micro enzymelinked immunosorbent assay (ELISA) for T. gondii antibodies, under the assumption that a positive antibody titre (IgG) reflects chronic infection and the presence of tissue cysts within the CNS.
MATERIALS AND METHODS

Patients and their sera
In this study, 50 patients with cryptogenic epilepsy were selected from patients who applied to Erciyes University Medical Faculty Neurology Department between 1999-2002. All patients had normal MRI of the brain, no family history of epilepsy, no history of head trauma, brain surgery, or previous meningitis/encephalitis, and no history of alcoholism. We also selected 50 patients with known cause epilepsy (13 head trauma, 12 family history of epilepsy, 9 brain surgery, 8 previous encephalitis, 8 history of alcoholism) and 50 healthy volunteers as control groups. 5-ml blood was taken from all patients and healthy volunteers under sterile conditions. Blood samples were centrifuged at 1000 rpm and sera separated and were stored at −20 • C until the analysis.
Serologic technique
We used the micro ELISA technique for T. gondii. Anti-T. gondii IgG and IgM antibodies ELISA kit provided from EUROIMMUN commercial manufacturer. We followed the manufacturer's instructions.
Statistic
For statistical analyses, SPSS V.9.0 for Windows pocket programme was used.
RESULTS
In our study, IgG titers of 27 of 50 (54%) cases in the cryptogenic epilepsy group, 11 of 50 (22%) cases in the known cause epilepsy group and 9 of 50 (18%) cases in the non-epileptic healthy volunteers were tested as positive. IgM titers tested as negative in all of the groups by ELISA (Table 1) . Positive optic density (OD) values were obtained for anti-T. gondii IgG antibody and were changed into international units (IU) according to test procedure.
The percentage of anti T. gondii IgG positive antibody in cryptogenic epilepsy patients (54%) was found to be greater than known cause epilepsy patients (22%) and non-epileptic healthy volunteers (18%). Thus, the results indicate a statistically significant difference between the cryptogenic epilepsy group and the other two groups (X 2 = 18.095, P < 0.01).
All patients and controls lived in Middle Anatolia, Turkey. The gender distribution of the patients and controls were similar; 31 women and 19 men for the cryptogenic epilepsy group, 29 women and 21 men for the known cause epilepsy group and 23 women and 27 men for the non-epileptic healthy volunteers. The age distributions were also similar, with a mean age of 37.82 ± 16.64 years among cryptogenic epilepsy patients, 35.78 ± 13.53 years among known cause epilepsy patients and 34.02±13.85 years among healthy volunteers. Table 1 : Results of anti-T. gondii antibodies analysis in cryptogenic epilepsy patients and in control groups.
IgG (+) Total
Cryptogenic epilepsy 27 (54%) 50 Known cause epilepsy 11 (22%) 50 Healthy volunteer 9 (18%) 50 X 2 = 18.095; P < 0.01.
DISCUSSION
T. gondii is found in two different stages in humans. The actively proliferating intracellular forms are called trophozoites or tachyzoites and are crescent shaped. Many different tissues may be parasitised by these organisms, particularly lung, heart, lymphoid organ, and CNS tissues. The resting forms or cyst stages are found in the tissue and contain the more slowly developing bradizoites 12 .
Toxoplasmosis can vary from an asymptomatic, self-limiting infection to a fatal disease, as seen in patients with congenital infections or in debilitated patients in whom underlying conditions may influence the final outcome of the infection. In immunocompramised patients, the infection most often involves the nervous system, with diffuse encephalopathy, meningoencephalitis, or cerebral mass lesions 12 .
Toxoplasma encephalitis (TE) has been reported as a life-threatening opportunistic infection among patients with AIDS. In one study of 41 AIDS patients, 47.4% of Toxoplasma sero-positive patients developed CNS toxoplasmosis. This percentage is considerably higher than the previously estimated risk percentages of 12-18% for the development of CNS involvement 13 . Overall, approximately 2.5% of AIDS patients have been diagnosed with cerebral toxoplasmosis 14 .
In the mouse model, there is evidence of focal inflammation with disrupted bradycysts 15 . Bradycysts mature slowly and have been shown to eventually lyse in the immunocompotent host, re-establishing chronic infection, and in the process, producing microscopic scars (glial nodules) 11 .
We found only one study of investigation of anti-T. gondii antibodies by ELISA among epileptic patients 4 . This study was carried out by Stommel et al. in 2001 . They identified 22 patients with cryptogenic epilepsy and on the basis of the ELISA values, 75% of the 22 patients had greater T. gondii antibody titers than the median titer observed among the 23 controls.
In our study, the sero-positivity rate for antiToxoplasma IgG antibodies of cryptogenic epilepsy patients (54%), indicates chronic infection, was found to be greater than the known cause epilepsy patients (22%) and non-epileptic healthy volunteers (18%). Anti-Toxoplasma IgM antibodies, indicating acute infection, were found to be negative in all of the groups. These results are similar and confirm the results of Stommel et al. If these results are verified with greater number of epileptic patients by other researchers, there may be new approaches to the treatment of cryptogenic epilepsy.
